Washburn Capital Management, Inc. Pa Vmed Inc. Transaction History

Washburn Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$0.57 - $34.65 $5,699 - $346,500	10,000 New	10,000 $9,000
Q4 2021 Feb 01, 2022	SELL	$2.46 - $8.74 $40,590 - $144,210	-16,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.1 - $9.39 $10,200 - $18,780	2,000 Added 13.79%	16,500 $140,000
Q2 2021 Aug 02, 2021	BUY	$3.95 - $6.88 $57,275 - $99,760	14,500 New	14,500 $93,000
Q4 2020 Jan 28, 2021	SELL	$1.73 - $2.13 $21,625 - $26,625	-12,500 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$1.75 - $2.65 $4,375 - $6,625	2,500 Added 25.0%	12,500 $26,000
Q1 2020 May 04, 2020	BUY	$1.15 - $3.29 $11,500 - $32,900	10,000 New	10,000 $20,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Washburn Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Washburn Capital Management, Inc. with notifications on news.